Executive Summary
This report summarizes the financial performance of Alvio Labs for Q1 2025 (January 1 – March 31, 2025). The company reported a net loss of €10,966.85, driven primarily by cost of goods sold (€10,350) and operating expenses (€617). No revenue was recorded during this period, indicating the company remains in a pre-revenue development phase. Cash position stands at €532.14 with net liquidity of €126.24 after accounting for outstanding payables. The company has received significant director funding totaling €14,543.09 to support operations.
Profit & Loss Statement
| Item | EUR |
| Revenue | — |
| Sales Revenue | €0.00 |
| Total Revenue | €0.00 |
| Cost of Sales | |
| Cost of Goods Sold | €10,350.00 |
| Total Cost of Sales | €10,350.00 |
| Gross Profit | -€10,350.00 |
| Operating Expenses | |
| Bank Fees | €10.00 |
| Consulting & Accounting | €405.90 |
| Software Expenses | €2.68 |
| R&D | €198.27 |
| Total Operating Expenses | €616.85 |
| Net Loss | -€10,966.85 |
Balance Sheet (Mar 31, 2025)
| Item | 2025 | 2024 |
| ASSETS |
| Cash - Revolut EUR | €532.14 | €0.00 |
| Total Assets | €532.14 | €0.00 |
| LIABILITIES |
| Accounts Payable | €405.90 | €0.00 |
| Director's Current A/c | €13,993.09 | €0.00 |
| Director's Loan A/c | €550.00 | €0.00 |
| Total Liabilities | €14,948.99 | €0.00 |
| NET ASSETS | -€14,416.85 | €0.00 |
Cash Position
| Metric | EUR |
| Cash at Bank | €532.14 |
| Outstanding Receivables | €0.00 |
| Outstanding Payables | €405.90 |
| Net Liquidity | €126.24 |
Key Observations
Revenue: No revenue recorded in Q1 2025; company is in pre-revenue/development phase with focus on product development.
Expenses: Total expenses of €10,966.85 incurred, primarily cost of goods sold (€10,350) and operating expenses (€617). Major operating costs: consulting & accounting (€406) and R&D (€198).
Cash Position: Minimal cash balance of €532.14 with net liquidity of €126.24 after payables. Requires careful cash flow management.
Director's Funding: Significant director contributions via current account (€13,993) and loan account (€550) totaling €14,543 to support operations.
Operating Expense Breakdown
| Category | Amount (EUR) | % of Total |
| Consulting & Accounting | €405.90 | 65.8% |
| Research & Development | €198.27 | 32.1% |
| Bank Fees | €10.00 | 1.6% |
| Software Expenses | €2.68 | 0.4% |
| Total Operating Expenses | €616.85 | 100% |
Cost of Goods Sold Detail
| Description | Amount (EUR) |
| Development Costs - Sqillx Education | €10,350.00 |
| Total Cost of Goods Sold | €10,350.00 |
Director Funding Summary
| Type | Amount (EUR) |
| Director's Current Account | €13,993.09 |
| Director's Loan Account | €550.00 |
| Total Director Funding | €14,543.09 |
Q1 2025 Bank Transactions Summary
| Type | Count | Amount (EUR) |
| Director Loans (Receipts) | 2 | €550.00 |
| Bank Fees (Revolut) | 1 | -€10.00 |
| Software/Tool Purchases | 1 | -€5.18 |
| Net Bank Activity | 4 | €534.82 |
Major Vendor Payments (Q1 2025)
| Vendor | Description | Amount (EUR) | Date |
| Sqillx Education Private Limited | Full-Stack Engineer / Development Services | €3,450.00 | Jan 1, 2025 |
| Sqillx Education Private Limited | Development Services | €3,450.00 | Feb 1, 2025 |
| Sqillx Education Private Limited | Development Services | €3,450.00 | Mar 1, 2025 |
| Around Finance | Annual Accounts & Corporation Tax Return | €135.30 | Jan 1, 2025 |
| Around Finance | Annual Accounts & Corporation Tax Return | €135.30 | Feb 1, 2025 |
| Around Finance | €135.30 | Mar 1, 2025 |
| Secret (Tech Lab SAS) | Services | €193.09 | Feb 8, 2025 |
| Total Major Payments | €10,948.99 | |
Financial Ratios & Metrics
Liquidity
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Cash Ratio | 0.04 |
Leverage
| Debt-to-Assets | 28.1x |
| Debt-to-Equity | N/A |
| Net Debt | €14,417 |
Activity
| Monthly Burn Rate | €3,656 |
| Runway (months) | 0.1 |
| Expenses/Revenue | N/A |
Risk Assessment & Recommendations
Liquidity Risk (HIGH): With net liquidity of only €126.24 and monthly burn rate of approximately €3,656, the company has less than one month of runway. Immediate funding or revenue generation is critical.
Dependency Risk (HIGH): Heavy reliance on director funding (€14,543) indicates unsustainable financing structure. Need to establish revenue streams or external funding.
Recommendation: 1) Accelerate revenue generation activities; 2) Secure additional funding or reduce burn rate; 3) Monitor cash position weekly; 4) Consider cost optimization in non-critical areas.
Notes: 1) All figures in EUR. 2) Data sourced from Xero as of Mar 22, 2026. 3) Period: Jan 1 – Mar 31, 2025. 4) Ratios calculated based on period-end balance sheet. 5) Burn rate calculated as Q1 total expenses divided by 3 months.